WO2006096709A3 - Process for preparing amorphous salts - Google Patents

Process for preparing amorphous salts Download PDF

Info

Publication number
WO2006096709A3
WO2006096709A3 PCT/US2006/008064 US2006008064W WO2006096709A3 WO 2006096709 A3 WO2006096709 A3 WO 2006096709A3 US 2006008064 W US2006008064 W US 2006008064W WO 2006096709 A3 WO2006096709 A3 WO 2006096709A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparing amorphous
magnesium
amorphous salts
esomeprazole
omeprazole
Prior art date
Application number
PCT/US2006/008064
Other languages
French (fr)
Other versions
WO2006096709B1 (en
WO2006096709A2 (en
Inventor
Vijayabhaskar Bolugoddu
Jaydeepkumar Dahayabha Lilakar
Purandhar Koilkonda
Ramchandra Reddy Pingili
Amarnath Reddy Lekkala
Venkata Rambabu Kammili
Swarupa Reddy Dudipala
Sharat Pandurang Narasapur
Srinivasa Rao Malina
Ramulu Akula
Original Assignee
Reddys Lab Ltd Dr
Reddys Lab Inc Dr
Vijayabhaskar Bolugoddu
Jaydeepkumar Dahayabha Lilakar
Purandhar Koilkonda
Ramchandra Reddy Pingili
Amarnath Reddy Lekkala
Venkata Rambabu Kammili
Swarupa Reddy Dudipala
Sharat Pandurang Narasapur
Srinivasa Rao Malina
Ramulu Akula
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr, Vijayabhaskar Bolugoddu, Jaydeepkumar Dahayabha Lilakar, Purandhar Koilkonda, Ramchandra Reddy Pingili, Amarnath Reddy Lekkala, Venkata Rambabu Kammili, Swarupa Reddy Dudipala, Sharat Pandurang Narasapur, Srinivasa Rao Malina, Ramulu Akula filed Critical Reddys Lab Ltd Dr
Priority to EP06737257A priority Critical patent/EP1856101A4/en
Priority to CA002600456A priority patent/CA2600456A1/en
Publication of WO2006096709A2 publication Critical patent/WO2006096709A2/en
Publication of WO2006096709A3 publication Critical patent/WO2006096709A3/en
Publication of WO2006096709B1 publication Critical patent/WO2006096709B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)

Abstract

Amorphous solid omeprazole magnesium or esomeprazole magnesium is prepared by subjecting a solution of omeprazole magnesium or esomeprazole magnesium to flash evaporation, such as by using an agitated thin film drier-vertical.
PCT/US2006/008064 2005-03-08 2006-03-07 Process for preparing amorphous salts WO2006096709A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06737257A EP1856101A4 (en) 2005-03-08 2006-03-07 Process for preparing amorphous salts
CA002600456A CA2600456A1 (en) 2005-03-08 2006-03-07 Process for preparing amorphous salts

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IN227/CHE/2005 2005-03-08
IN227CH2005 2005-03-08
US67314205P 2005-04-20 2005-04-20
US60/673,142 2005-04-20
IN1543CH2005 2005-10-25
IN1543/CHE/2005 2005-10-25

Publications (3)

Publication Number Publication Date
WO2006096709A2 WO2006096709A2 (en) 2006-09-14
WO2006096709A3 true WO2006096709A3 (en) 2006-12-21
WO2006096709B1 WO2006096709B1 (en) 2007-01-18

Family

ID=36953969

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/008064 WO2006096709A2 (en) 2005-03-08 2006-03-07 Process for preparing amorphous salts

Country Status (3)

Country Link
EP (1) EP1856101A4 (en)
CA (1) CA2600456A1 (en)
WO (1) WO2006096709A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
CA2889878A1 (en) 2007-02-21 2008-08-28 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
FR2959509B1 (en) 2010-05-03 2012-07-13 Prod Chim Auxiliaires Et De Synthese PRECURSOR PHASE AND USE THEREOF FOR PREPARING MAGNESIUM TETRAHYDRATE SALT OF AN OMEPRAZOLE ENANTIOMER

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713495B1 (en) * 1999-11-16 2004-03-30 Bernard Charles Sherman Magnesium omeprazole

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0110926A (en) * 2000-05-15 2004-02-17 Ranbaxy Lab Ltd New amorphous forms of omeprazole salts and their preparation process
US6894066B2 (en) * 2002-05-09 2005-05-17 Bernard Charles Sherman Magnesium salt of S-omeprazole
WO2004037253A1 (en) * 2002-10-22 2004-05-06 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713495B1 (en) * 1999-11-16 2004-03-30 Bernard Charles Sherman Magnesium omeprazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1856101A4 *

Also Published As

Publication number Publication date
WO2006096709B1 (en) 2007-01-18
EP1856101A4 (en) 2009-10-21
WO2006096709A2 (en) 2006-09-14
CA2600456A1 (en) 2006-09-14
EP1856101A2 (en) 2007-11-21

Similar Documents

Publication Publication Date Title
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
CL2012000929A1 (en) Process for obtaining glucose derivatives by coupling between an organometallic zinc compound and a protected glucose derivative and its subsequent deprotection.
WO2009079008A8 (en) Benzopyrans and analogs as rho kinase inhibitors
NZ591818A (en) Processes for the preparation of sglt2 inhibitors
WO2008084223A3 (en) Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
MX2009003257A (en) Process for synthesis of phenoxy diaminopyrimidine derivatives.
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
WO2006108792A8 (en) New heterocyclylethylbenzamide derivatives
WO2008083950A8 (en) Spirocyclic tetronic acid derivatives
WO2006108791A3 (en) Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
WO2011071314A3 (en) Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms
RS53173B (en) Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
NO20082116L (en) Chemical process for preparing an amido-phenoxybenzoic acid compound
WO2006096709A3 (en) Process for preparing amorphous salts
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
EP2184328A3 (en) Subphthalocyanine derivative having phosphorus derivative as axially substituted group, method for manufacturing the same and optical film using the same
NZ702797A (en) Method for producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazol-3-yl]pyridine-2-carbonitrile, and intermediate thereof
WO2009084023A3 (en) Amorphous ramelteon and process for the preparation thereof
EA200901626A1 (en) METHOD OF GETTING ALMOTRIPTANE OF HIGH PURITY
WO2010018218A3 (en) Improved fluoridation of iodonium salts
WO2007031845A3 (en) Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
EP2047917A4 (en) Method for producing organic thin film by using film physical property improving process
WO2009065872A3 (en) Processes for the synthesis of varenicline l-tartrate
WO2008155780A3 (en) Improved process for the preparation of pure rabeprazole
WO2008077035A3 (en) Processes for the preparation of levetiracetam

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2600456

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006737257

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 4198/CHENP/2007

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: RU